The levator aponeurosis exposed.
A case of bilateral upper eyelid ptosis in an HIV-infected patient with severe antiretroviral-associated facial lipodystrophy is presented. The features, treatment, and outcome are discussed. Dehiscence of the levator aponeurosis may be directly associated with highly active antiretroviral therapy-induced lipodystrophy.
Stack
Rebecca R
RR
Department of Ophthalmology, Christchurch Hospital, Christchurch, New Zealand.
Thompson
Andrew M
AM
Weatherhead
Robert G
RG
Pithie
Alan
A
D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D019882:Blepharoplasty / Q000379:methods*; D001763:Blepharoptosis / Q000209:etiology* / Q000601:surgery; D016049:Didanosine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D039682:HIV-Associated Lipodystrophy Syndrome / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D019888:Nelfinavir / Q000627:therapeutic use; D009801:Oculomotor Muscles / Q000473:pathology* / Q000601:surgery; D018119:Stavudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D018119:Stavudine; D019888:Nelfinavir; D016049:Didanosine